jueves, 4 de octubre de 2018

Vorinostat | Clinical Trials, Side Effects | AIDSinfo

Vorinostat | Clinical Trials, Side Effects | AIDSinfo

AIDSinfo logo Image



Vorinostat

 Other Names: MK-0683, VOR, Zolinza, suberoylanilide hydroxamic acid (SAHA)Drug Class: Latency-Reversing AgentsMolecular Formula: C14 H20 N2 O3Registry Number: 149647-78-9 (CAS)Chemical Name: 8-(hydroxyamino)-8-oxo-N-phenyl-octanamideChemical Class: Other Carboxylic Acid DerivativesOrganization: Merck & Co., Inc.Phase of Development: Vorinostat is in Phase II development as a latency-reversing agent for HIV.

(Compound details obtained from ChemIDplus Advanced,1 NIAID Therapeutics Database,and Treatment Action Group website3)

No hay comentarios:

Publicar un comentario